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Abstract
Background: The number of revision total knee arthroplasties (TKAs) in Asian countries is projected to increase
with the rapid growth of primary TKA. We investigated the factors associated with the incidence of revision TKA
using a nationally representative database.
Methods: Data collected by the Health Insurance Review Agency of Korea, from 260,068 TKA patients between
2007 and 2012, were used to estimate the incidence rate and cumulative incidence of revision TKA according to
age, gender, and hospital TKA and prosthesis manufacturer volume. Age, hospital, and manufacturer volume were
categorized into three groups. The incidence rates and cumulative incidences of revision TKA were computed by
combining age and gender, and by combining hospital and prosthesis manufacturer volume.
Results: Incidence rates per 100,000 person-years were as follows: 1) by age: < 65 years, 447.2; 65–74 years,
363.7; ≥ 75 years, 270.9, 2) by gender: male, 537.8; female, 346.1; 3) by hospital volume (procedures/year): < 20, 536.9;
20–199, 432.3; ≥ 200, 300.1; and 4) by manufacturer volume (prostheses/year): < 1500, 772.3; 1500–3999, 453.9; ≥ 4000,
345.6. The revision TKA incidence rate in young males was significantly higher compared to that in elderly females. The
difference in cumulative incidence, between hospitals with an annual volume of < 20 procedures and those
with a volume of 20–199 procedures, was reduced for manufacturers with an annual volume of≥ 4000. Similarly, the
difference in cumulative incidence between manufacturers with an annual volume of <1500 prostheses and those with
a volume of 1500–3999 prostheses was reduced in hospitals with an annual volume of≥ 200.
Conclusion: Revision TKA incidence varied according to age, gender, and hospital and manufacturer volume. This data
could inform clinical decisions and healthcare strategies.
Keywords: Age, Gender, Hospital volume, Incidence, Manufacturer volume, National Claim Registry, Revision total knee
arthroplasty
Background
Total knee arthroplasty (TKA) is an efficacious and
cost-effective pain-relieving procedure that improves
mobility and quality of life in patients with severe
knee arthritis [1–3]. TKA use has increased in nu-
merous countries, particularly in Asia, commensurate
with an aging population and continued socioeco-
nomic development [4–7]. Changes to contemporary
TKA prosthesis design and surgical techniques (including
a greater number of arthroplasty-specific hospitals), to-
gether with patient indications and medical circum-
stances, impact upon the decision to apply TKA. In a
recent study, the increased rate of TKA use in Korea was
markedly higher compared to developed countries [5]; re-
vision TKA is also projected to increase commensurate
with this increase in primary TKA [8, 9].
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Revision TKA represents a major challenge for health-
care providers and patients, and is associated with a sub-
stantial economic burden likely to affect national
medical and insurance policies [10–12]. Many studies
have reported on the epidemiology of, and factors asso-
ciated with, revision TKA [4, 8–10, 13–15], primarily in
the context of large single-center, or multi-center,
settings [4, 13, 15]. Therefore, smaller hospitals, which
account for a substantial proportion of the total number
of TKA procedures performed, may be underrepresented
such that drawing definitive conclusions regarding na-
tional revision TKA incidence is problematic [16–18].
Several studies conducted in Norway, Australia and
Sweden have addressed this issue by using national
(or in the US, statewide [Medicare]) arthroplasty data-
bases [9, 19–22].
However, to date only one Asian study has used na-
tional databases to evaluate revision TKA use [23].
Given the increasing popularity of TKA in Asia, which
accounts for > 60 % of the world’s population, and the
different characteristics and medical circumstances of
Asian vs. Western patients, revision TKA use in this
continent warrants further study [4–7].
Several reports indicate an association between TKA
outcomes and the number of procedures performed at
hospitals (hospital volume) [9, 17, 19, 21, 24, 25].
However, only two Asian studies have assessed the im-
pact of hospital stay duration, cost of hospitalization and
postoperative infection status, and not specifically in the
context of revision TKA [6, 26]. Furthermore, to our
knowledge there has been no previous investigation of
the potential relationship between the frequency with
which particular manufacturers’ prostheses are used
(prosthesis manufacturer volume) and revision TKA
incidence.
Therefore, we investigated revision TKA incidence
according to age group, gender, and hospital and
prosthesis manufacturer volume, using a nationally
representative Health Insurance Review Agency (HIRA)
database containing reimbursement records between
2007 and 2012.
Methods
This study used a retrospective cohort design using
national data collected between 2007 and 2012 by the
Health Insurance Review Agency (HIRA) of Korea, a
non-profit organization supported by the Korean
Ministry of Health and Welfare. All Koreans are obli-
gated to contribute to the National Health Insurance
Service, and pay hospitals or clinics 20–30 % of the
total cost for medical procedures excluding cosmetic
surgery or novel, unproven treatments. The remaining
70–80 % of costs are recouped by hospitals and
clinics upon submission of claims to the HIRA detail-
ing the health care services provided (including diag-
noses, procedures, hospitalization period, and medical
costs incurred). The HIRA reviews each claim, following
which the National Health Insurance Corporation issues
expenses according to the decision of the HIRA. Approxi-
mately 97 % of the Korean population is enrolled in this
system; the remaining 3 % are under the Medical Aid Pro-
gram, which is also supervised by the HIRA such that all
information concerning medical practices can ultimately
be obtained from the HIRA database. The HIRA database
can be regarded as a complete enumeration; the subjects
of this study were essentially all of the patients undergoing
primary or revision TKA in Korea during the study
period. Therefore, unlike typical studies using sampling
databases, we did not need to make statistical assumptions
for the study population. Similarly, other studies using the
HIRA database did not perform statistical calculations for
assumptions [23, 27, 28].
We identified all primary total knee replacement
arthroplasties performed in Korea (denoted by HIRA
Fig. 1 Cumulative incidence per 100,000 primary TKA patients of revision TKA procedures conducted between 2007 and 2012
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codes N0712 and N2072) between January 1st, 2007
and December 31st, 2012. Patients between 45 and
90 years of age at the time of their primary TKA
were included, with those also undergoing revision
TKA identified by the codes N1712 and N3712, re-
gardless of the reasons for surgery. If revision TKA
codes preceded primary TKA codes, the data were
excluded. A material code for the femoral component
(E200-) was used to identify the prosthesis manufac-
turer in each case.
Data from a total of 260,068 patients who underwent
primary TKA during the study period were analyzed.
Their mean age was 68.8 ± 6.9 years, and there were
30,388 (11.7 %) males and 229,680 (88.3 %) females.
We calculated the incidence rate (per 100,000 primary
TKA patient-years) and cumulative incidence (per 100,000
primary TKA patients) of revision TKA, with the period
between primary and revision TKA representing the failure
time. The incidence rates and cumulative incidences of re-
vision TKA were computed according to age group, gender,
and hospital and prosthesis manufacturer volume. The
cumulative incidence of revision TKA was computed
by combining age and gender and by combining hos-
pital and prosthesis manufacturer volume. There were
three age groups (<65, 65–74, and ≥ 75 years), in line
with a previous study that analyzed the risk factors
for TKA failure [13]. When deciding the cut-off
values and numbers of groups for hospital volumes or
prosthesis manufacturer volumes, we attempted to de-
termine the number of groups and cut-off values that
would allow optimal subject numbers in each group
and the most noticeable difference in the revision rate
among the groups based on hospital volumes or prosthesis
manufacturer volumes. Based on the results, hospital vol-
ume was categorized into three groups: < 20, 20–199,
and ≥ 200 primary procedures/year. These cut-offs were
similar to those used in a study that evaluated the cost-
effectiveness of TKA according to hospital volume [29].
Similarly, prosthesis manufacturer volume was also cate-
gorized into three groups: < 1500, 1500–3999 and ≥ 4000
prostheses/year.
Results
During the study, 2,669 (1 %) patients received revision
surgery, the cumulative incidence of which increased
linearly over time (Fig. 1). Of these patients, 1,612
(60.4 %) underwent revision surgery at the same hospital
at which their primary TKA was performed; in 1,257
(47.1 %) patients, the prosthesis used during their
primary and revision surgeries were from the same
manufacturer. In 1,045 revision surgeries, both the
hospital and prosthesis manufacturer were identical to
those of the primary surgery (39.2 %).
The overall incidence rate of revision TKA was 367.3/
100,000 person-years; the incidence was higher in the
youngest age group and males (Table 1). In the detailed
analysis subdivided by age groups, the incidence in pa-
tients fifty years old or younger was extremely high
(Fig. 2). When comparing the groups defined by age and
Table 1 Incidence of revision total knee arthroplasty according
to age and gender
Study cohort (n = 260,068)
Patient factor Number of
patients (%)
Incidence rate (per 100,000
person-years)
Age
<65 years 65,017 (25.0) 447.2
65–74 years 140,693 (54.1) 363.7
≥75 years 54,358 (20.9) 270.9
Gender
Male 30,388 (11.7) 537.8
Female 229,680 (88.3) 346.1
Fig. 2 Incidence rate per 100,000 primary TKA patient-years of revision TKA by age group
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gender, the youngest male group had the highest inci-
dence rate of revision TKA (Fig. 3).
Lower hospital and prosthesis manufacturer vol-
umes were associated with higher revision TKA inci-
dence rates (Table 2) and cumulative incidences
(Figs. 4 and 5). However, during comparison of
groups defined according to hospital and prosthesis
manufacturer volume, the cumulative incidence of revision
TKA, of lower- (<20 procedures/year) and intermediate-
volume hospitals (20–199 procedures/year) was similar
when prosthesis manufacturer volume was high (≥4000
prostheses/year; Fig. 6). Similarly, the difference in cumula-
tive incidence of revision TKA, between higher- (≥4000
prostheses/year) and intermediate- (1500–3999 prostheses/
year) prosthesis manufacturer volumes, was lower in the
context of higher-volume hospitals (≥200 procedures/year;
Fig. 7).
Discussion
This study evaluated information pertaining to revision
TKA operations performed in Korea between 2007 and
2012, using a near-complete HIRA dataset. In particular,
we assessed for the first time the association between
prosthesis manufacturer volume and revision TKA
incidence.
Few studies conducted in other Asian countries have
dealt with the epidemiology of revision TKA. A study
from Taiwan using national data reported that the num-
ber of revision TKAs increased by 23 % from 1998 to
2009 [23]. In that study, old age and male gender were
associated with increases in the revision TKA rates,
which concurred with our results. The proportion of fe-
males among those undergoing revision TKA was
72.2 % in the Taiwan study and 81 % in the Japan study
[4], both of which were lower than our result of 88.3 %.
Higher revision rate was observed in younger patients,
which accords with the results of studies of Western
populations [2, 9, 15, 18, 30]. McCalden et al. [30] re-
ported higher rates of aseptic loosening, instability,
wear and/or osteolysis in younger patients, probably
due to their greater levels of physical activity. Fur-
thermore, younger patients are more likely to present
with complex preoperative conditions, such as previous
failed surgeries or posttraumatic deformities, which could
Fig. 3 Comparison of the trends in age-specific incidence rates between males and females per 100,000 primary TKA patient-years of
revision TKA
Table 2 Incidence of revision total knee arthroplasty according to hospital and prosthesis manufacturer volume
Study cohort (n = 260,068)
Factor Volume Number of patients (%) Incidence rate (per 100,000 person-years)
Hospitala <20 19,335 (7.4) 536.9
20–199 99,797 (38.4) 432.3
≥200 140,936 (54.2) 300.1
Manufacturerb <1,500 8,746 (3.4) 772.3
1500–3999 30,153 (11.6) 453.9
≥4000 221,169 (85.0) 345.6
aMean annual number of primary total knee arthroplasties performed in each hospital during the study period
bMean annual number of prostheses applied to patients undergoing primary total knee arthroplasty during the study period
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lead to increased revision rates [30]. Surgeons may
also be less likely to recommend revision TKA for
elderly patients [2].
Our results also accord with those from Western
countries demonstrating higher rates of revision TKA in
males compared to females [2, 9, 15, 18, 31–35]; for ex-
ample, Singh et al. [35] reported significantly higher
rates of revision TKA, at 5 years post-primary TKA in
males. Higher rates of polyethylene wear and osteolysis
in male patients may be due to gender differences in
knee biomechanics of and/or physical activity levels,
thereby leading to higher rates of revision TKA [31, 33].
Higher infection rates in male TKA patients may also be
a contributory factor [33]. Revision TKA was particularly
common in younger males, such that the decision to
apply TKA should be receive particularly careful consid-
eration in this population.
Our data accord with previous studies in which lower
hospital volume was associated with higher rates of revi-
sion TKA [9, 18, 19, 21, 36]. The mechanism underlying
this relationship remains unknown. Kreder et al. [36]
suggested that the difference in revision rates observed
between lower- and higher-volume hospitals, at 1-year
post-primary TKA, may be attributable to differences in
expertise among healthcare providers rather than to
differences in the prosthesis equipment itself. Hospital
facilities and equipment, the experience of the surgeon,
and the use of a selective referral system (i.e., sending
patients to hospitals associated with good TKA outcomes)
may all represent important factors.
Our analysis of the relationship between incidence
rates and prosthesis manufacturer volume, which has
not been assessed in previous studies, was similar to that
observed for hospital volume. A surgeon's experience
with a particular manufacturer’s prosthesis, and its de-
sign and quality, may influence revision TKA incidence.
In our study, the cumulative incidences of revision TKA
in intermediate- (20–199 procedures/year) and higher-
volume hospitals (≥200 procedures/year) (Fig. 4) were
similar to those when the prosthesis manufacturer
Fig. 4 Cumulative incidence per 100,000 primary TKA patients of revision TKA in accordance with hospital volume
Fig. 5 Cumulative incidence per 100,000 primary TKA patients of revision TKA in accordance with prosthesis manufacturer volume
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volume exceeded 4000 prostheses/year (Fig. 6). However,
we observed a decrease in the cumulative incidence of re-
vision TKA in lower-volume hospitals (<20 procedures/
year) for manufacturers with an annual volume of ≥ 4000
(Figs. 4 and 6). Combined with our other results, our find-
ings suggest that the use of primary TKA prostheses with
a higher prosthesis manufacturer volume (≥4000 pros-
theses/year) would reduce the revision rate, and its effect
seems to be more helpful in lower-volume hospitals.
This study had several limitations. First, in cases of in-
fection, patients managed by debridement or replace-
ment of the polyethylene insert were not included in the
study; only patients who underwent revision knee
arthroplasty were included. Therefore, the TKA revision
rates reported herein are not representative of the over-
all TKA failure rate. Second, we assessed incidence ac-
cording to hospital and prosthesis manufacturer volume
only, and evaluated neither the experience of surgeons
nor the frequency with which a particular model of pros-
thesis was used. Third, the particular characteristics of
Korean TKA patients (e.g., high proportion of females,
small proportion of procedures performed by lower-
volume hospitals [<20 procedures/year], and different
living arrangements) may limit the generalizability of
our data [16, 17, 37]. Fourth, although the same manu-
facturer produces different components, we did not dis-
tinguish the component type from a material code, but
identified each manufacturer.
Conclusions
Total knee arthroplasty performed in young, male
patients, at lower-volume hospitals and with lower
prosthesis manufacturer volumes, were associated with a
higher incidence of revision TKA. In addition to age and
gender, revision TKA incidence also varied according to
hospital and prosthesis manufacturer volume. These
data could inform clinical decisions and healthcare strat-
egies; further studies are required to evaluate the associ-
ation between revision TKA incidence and prosthesis
manufacturer volume in other ethnic populations.
Fig. 6 Cumulative incidence per 100,000 primary TKA patients of revision TKA in accordance with hospital volume when the prosthesis
manufacturer volume was≥ 4000 prostheses/year
Fig. 7 Cumulative incidence per 100,000 primary TKA patients of revision TKA in accordance with prosthesis manufacturer volume when the
hospital TKA volume was≥ 200 procedures/year
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